Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies-Reference-Cited by-同舟云学术

Tau Protein, Aβ42 and S-100B Protein in Cerebrospinal Fluid of Patients with Dementia with Lewy Bodies

Published:2005 Issue:2-3 Volume:19 Page:164-170
ISSN:1420-8008
Container-title:Dementia and Geriatric Cognitive Disorders
language:en
Short-container-title:Dement Geriatr Cogn Disord

Author:

Mollenhauer Brit,Cepek Lukas,Bibl Mirko,Wiltfang Jens,Schulz-Schaeffer Walter J.,Ciesielczyk Barbara,Neumann Manuela,Steinacker Petra,Kretzschmar Hans A.,Poser Sigrid,Trenkwalder Claudia,Otto Markus

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Cognitive Neuroscience,Geriatrics and Gerontology

Reference34 articles.

1. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

2. Neuroleptic sensitivity in patients with senile dementia of Lewy body type.

3. Reduction of ?-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease

4. Improved discrimination of AD patients using β-amyloid(1-42) and tau levels in CSF

5. Cerebrospinal fluid levels of Aβ42 and tau: potential markers of Alzheimer’s disease

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of peptide biomarkers in life analysis based on liquid chromatography–mass spectrometry technology;BioFactors;2022-07

2. The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy “In Vivo” in the Differential Diagnosis of Alzheimer’s Dementia;Current Alzheimer Research;2019-09-04

3. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study;Alzheimer's & Dementia;2019-04-06

4. In vivo Prevalence of Alzheimer Biomarkers in Dementia with Lewy Bodies;Dementia and Geriatric Cognitive Disorders;2019

5. The underexplored question of β-amyloid monomers;European Journal of Pharmacology;2017-12